GRIDX (Grid Exponential) is a Latin America-based science-driven venture builder and early-stage venture capital firm focused on creating and scaling biotechnology and life-science startups from academic and laboratory research; it operates a structured "company builder" model where scientists and entrepreneurs are selected through a discovery and transformation process to co-found startups, particularly in non-therapeutic biotech, agriculture, bioindustry, and human health applications; the firm provides early capital, typically around seed-stage funding, and actively participates in team formation, venture creation, and operational development; GRIDX manages multiple cohorts across Latin America and has built a portfolio of 90+ startups with a strong emphasis on converting scientific research into scalable commercial ventures; overall it functions as a hybrid venture capital fund and venture studio specializing in deep biotech company creation.